Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Drug Testing
    Drug Testing
    Drug Testing
    Ebook325 pages8 hours

    Drug Testing

    By John Fay

    2/5

    ()

    Read preview

    About this ebook

    Drug Testing focuses on the contributions of drug testing in the identification of the state of drug abuse and the implementation of policies and regulations making drug use unacceptable either socially or in the workplace. The book first gives an overview of drug-testing policy, facilitating drug testing and treatment, challenges to drug-testing programs, and state, local, and federal legislation on drug testing. The text then defines the problem of drug abuse, including dimensions of abuse, defining the problem and the needs of employers, employing a drug abuse survey, and treatment modalities. The manuscript ponders on the development of a drug-testing policy, education of employees, and training of supervisors. Discussions focus on the nature of learning, principles of supervision, training process, program implementation, basic assumptions, final policy content, and problematic issues. The implementation of a drug-testing program, collection of specimens for drug testing, and understanding the drug testing program are also underscored. The publication is a valuable reference for readers interested in drug testing policies, treatment, and effects of drug abuse in the workplace.
    LanguageEnglish
    PublisherElsevier Science
    Release dateOct 22, 2013
    ISBN9781483165035
    Drug Testing
    Author

    John Fay

    Mr. Fay was a special agent of the U.S. Army Criminal Investigation Division (CID) and later the Director of the National Crime Prevention Institute at the University of Louisville. He has held security management positions in the petroleum industry while teaching at the university level. He holds the Master of Business Administration degree from the University of Hawaii, and is a well-known and respected author of many books, including Butterworth's Security Dictionary: Terms and Concepts, Drug Testing, Encyclopedia of Security Management: Techniques and Technology, and Model Security Policies, Plans, and Procedures, all by Butterworth-Heinemann.Was a special agent of the U.S. Army Criminal Investigation Division (CID) and later the Director of the National Crime Prevention Institute. Former manager of security for British Petroleum's operations in the Gulf of Mexico. He was previously an adjunct professor at the University of North Florida and the University of Houston.

    Related to Drug Testing

    Related ebooks

    Organizational Behaviour For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      A Commitment To Best Practice

      Feb 10, 2020

      Few retailers or brand owners will consider doing business with a supplier that does not have certification to a global standard. Certification helps a business improve its product, management systems, quality control and overall competitiveness. The

      2 min read

    • Article

      Opinion: From Bench To Bedside, Biologics Require Excellence At Every Stage

      Feb 13, 2020

      Quality and trust go together. As an industry, biologic manufacturers must deliver on quality. Public trust of sophisticated biological products will follow.

      3 min read

    • Article

      The Debate

      May 2, 2020

      The Debate
      1 min read

    • Article

      Opinion: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks

      Jan 18, 2019

      It's a long and winding road to bringing diagnostic innovations to the U.S. market. We need to clear the roadblocks.

      5 min read

    • Article

      Q&A on At-Home Rapid Tests

      Jan 14, 2022

      Q&A on At-Home Rapid Tests
      12 min read

    • Article

      Opinion: FDA Is Smashing The Status Quo For Regulatory Science

      Oct 14, 2019

      The FDA can enable innovation by being a partner in advancing new approaches to drug development and regulatory science. Its recent reorganization signals a revolutionary shift in regulatory velocity.

      5 min read

    • Article

      Know Before Your Inspection

      Jun 22, 2020

      Know Before Your Inspection
      2 min read

    • Article

      Opinion: Real-world Data Can Help Make Better Drugs And Do It Faster

      May 2, 2018

      Relying solely on clinical trials to demonstrate the safety and effectiveness of new drugs can be risky. Real-world data can help.

      4 min read

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      OMB Proposes Science-Based Guidance for Modernizing Regulatory Review

      Jun 2, 2023

      Update: The OMB has extended the comment deadline for Circular A-4 to June 20. In April, President Biden issued an Executive Order on Modernizing Regulatory Review with some critical steps to help update and improve guidance for agency rulemaking pro

      3 min read

    • Article

      Getting To Develop A Vaccine

      Nov 26, 2020

      Getting To Develop A Vaccine
      1 min read

    • Article

      The World’s Best Hospitals2023

      Mar 10, 2023

      The World’s Best Hospitals2023
      9 min read

    • Article

      How Science-Based Targets Will Fuel Sustainability

      Jan 1, 2023

      WITH THE 2015 PARIS AGREEMENT, governments the world over made a commitment to limiting global temperature increases. Then in 2018, the Intergovernmental Panel on Climate Change (IPCC) warned that global warming must not exceed 1.5°C above pre-indust

      6 min read

    • Article

      Be Prepared

      Aug 19, 2019

      Be Prepared
      3 min read

    • Article

      Many Pharma Transparency Policies Are Vague, Ambiguous, and Contradictory

      Jul 26, 2017

      Overall, 95 percent of the 42 companies reviewed in the analysis — including the 25 largest drug makers, based on sales — had a publicly accessible policy.

      2 min read

    Related categories

    Reviews for Drug Testing

    2/5

    1 rating0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Drug Testing - John Fay

      Enjoying the preview?
      Page 1 of 1